The text discusses the screening for dihydropyrimidine dehydrogenase (DPD) deficiency and recommendations for fluoropyrimidine-based chemotherapies. It also includes information on tumor budding in solid cancers, the number of nodes needed to stage colon cancers, the efficacy of adjuvant chemotherapy in different stages of colon cancer, patterns of recurrence after resection for colonic cancer, and the clinical utility of colon cancer molecular subtypes. Additionally, it mentions the benefit of adjuvant chemotherapy for older patients with colon cancer and the impact of age on the efficacy of newer adjuvant therapies.